Lazard Asset Management
SURF

Lazard Asset Management’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Lazard Asset Management’s Portfolio SURF Stock Details SURF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-12,312
Closed -$58K – 2591
2021
Q4 		$58K Buy
12,312
+1,490
+14% +$9.62K ﹤0.01% 1676
2021
Q3 		$81K Buy
+10,822
New +$69.3K ﹤0.01% 1479
2021
Q2 		– Sell
-12,984
Closed -$101K – 2117
2021
Q1 		$101K Buy
+12,984
New +$130K ﹤0.01% 1203

Other funds holding SURF

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
AVAI
Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Lazard Asset Management's SURF Position: Q1 2022 in Review

Lazard Asset Management sold out of Surface Oncology, Inc. Common Stock (SURF) in Q1 2022, closing a stake of 12,312 shares — an estimated $58K sold.

Lazard Asset Management first reported a position in SURF in Q1 2021 and held it in 3 quarters. The position peaked at $101K in Q1 2021. 103 funds tracked by Wall St. Rank hold SURF as of Q1 2022.

  • Lazard Asset Management reported no remaining Surface Oncology, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Lazard Asset Management sold 12,312 Surface Oncology, Inc. Common Stock shares in Q1 2022, an estimated $58K.
  • Lazard Asset Management first reported a position in Surface Oncology, Inc. Common Stock in Q1 2021 and held it in 3 quarters.
  • Lazard Asset Management's Surface Oncology, Inc. Common Stock position peaked at $101K in Q1 2021.
  • 103 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q1 2022.

Based on Lazard Asset Management's 13F filing for Q1 2022, filed 13 May 2022.